During the past decade, Hopital de Pontchaillou; Medicine Interne - Hepatologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital de Pontchaillou; Medicine Interne - Hepatologie" are "Hepatitis B, Chronic" (2 trials), "Multiple Myeloma" (2 trials), "AL Amyloidosis" (1 trials) and "Primary Systemic (AL) Amyloidosis" (1 trials). Many other conditions were trialed in "Hopital de Pontchaillou; Medicine Interne - Hepatologie" in a lesser frequency.

Most popular intervention types in "Hopital de Pontchaillou; Medicine Interne - Hepatologie" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "NEOD001" (2 trials), "Placebo" (2 trials), "Lenalidomide" (1 trials), "Lenalidomide and low-dose dexamethasone" (1 trials) and "Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital de Pontchaillou; Medicine Interne - Hepatologie" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hopital de Pontchaillou; Medicine Interne - Hepatologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hopital de Pontchaillou; Medicine Interne - Hepatologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital de Pontchaillou; Medicine Interne - Hepatologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".